Paid Clinical Trials in Florida

Florida has 4,147 paid clinical trials enrolling now across cities including Miami, Tampa and Jacksonville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Florida include Mayo Clinic Jacksonville, Moffitt Cancer Center and University of Miami Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 25, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

3,687 clinical trials

↓ Download CSV

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

for Advanced Non-squamous Non-small-cell Lung Cancer

Sites in Miami, Fort Lauderdale +13 more locations

Sponsor: Genelux Corporation

Sex: All·Age: 18+

Code: NCT06463665·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

for Autoimmune Haemolytic Anaemia

Sites in Miami, Hialeah +21 more locations

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT07086976·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Lead-212 PSV359 Therapy for Patients With Solid Tumors

for Pancreatic Ductal Adenocarcinoma

Sites in Miami +10 more locations

Sponsor: Perspective Therapeutics

Sex: All·Age: 18 - 90

Code: NCT06710756·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

VTP-1000 in Adults With Celiac Disease

for Celiac Disease

Sites in Jacksonville, St. Petersburg +14 more locations

Sponsor: Barinthus Biotherapeutics

Sex: All·Age: 18 - 70

Code: NCT06310291·EARLY_Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

for Myasthenia Gravis

Sites in Miami +9 more locations

Sponsor: Kyverna Therapeutics

Sex: All·Age: 18 - 75

Code: NCT06193889·Phase 2, Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

for Glioblastoma (GBM)

Sites in Jacksonville +16 more locations

Sponsor: Diakonos Oncology Corporation

Sex: All·Age: 18+

Code: NCT06805305·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

for Soft Tissue Lesion

Sites in Naples +10 more locations

Sponsor: Galvanize Therapeutics, Inc.

Sex: All·Age: 18 - 100

Code: NCT05851430·Recruiting·Listed May 2023

Apply to this trial

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for Metastatic Castration-resistant Prostate Cancer

Sites in Miami, Port Saint Lucie +11 more locations

Sponsor: K36 Therapeutics, Inc.

Sex: Male·Age: 18+

Code: NCT07103018·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

The Pivotal Study of RapidPulseTM Aspiration System

for Acute Ischemic Stroke

Sites in Tampa, Jacksonville +13 more locations

Sponsor: RapidPulse, Inc

Sex: All·Age: 18 - 80

Code: NCT06029491·Recruiting·Listed Sep 2023

Apply to this trial

REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome

for Angelman Syndrome

Sites in Miami +16 more locations

Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All·Age: 2 - 50

Code: NCT06914609·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

for Colorectal Cancer

Sites in Gainesville, Miami Beach +10 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06428409·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

for Acute Myeloid Leukemia

Sites in Tampa +7 more locations

Sponsor: Orca Biosystems, Inc.

Sex: All·Age: 12 - 78

Code: NCT03802695·Phase 1·Recruiting·Listed Jan 2019

Apply to this trial

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for Multiple Myeloma

Drug: Elranatamab

Sites in Miami, Coral Gables +15 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06057402·Phase 4·Recruiting·Listed Sep 2023

Apply to this trial

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

for Guillain-Barre Syndrome

Sites in Jacksonville +11 more locations

Sponsor: Annexon, Inc.

Sex: All·Age: 12 - 85

Code: NCT07020819·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

for Invasive Mold Infections

Sites in Hollywood +18 more locations

Sponsor: Basilea Pharmaceutica

Sex: All·Age: 18+

Code: NCT06925321·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

for Prostate Cancer

Sites in Jacksonville +23 more locations

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18 - 100

Code: NCT05803941·Phase 4·Recruiting·Listed Apr 2023

Apply to this trial

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

for Chronic Kidney Disease

Drug: Finerenone

Sites in Hollywood +11 more locations

Sponsor: Bayer

Sex: All·Age: 1 - 18

Code: NCT05457283·Phase 3·Recruiting·Listed Jul 2022

Apply to this trial

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for Schizophrenia

Sites in Miami, Tampa +20 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18+

Code: NCT07105111·Phase 4·Recruiting·Listed Aug 2025

Apply to this trial

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

for Advanced Solid Tumor

Sites in Sarasota +2 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT04145622·Phase 1, Phase 2·Recruiting·Listed Oct 2019

Apply to this trial

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

for Recurrent Melanoma (Skin)

Drug: Nivolumab

Sites in Miami, Jacksonville +10 more locations

Sponsor: Perspective Therapeutics

Sex: All·Age: 18 - 90

Code: NCT05655312·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for Breast Cancer

Sites in Plantation, Tamarac +20 more locations

Sponsor: Celcuity Inc

Sex: All·Age: 18+

Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

for Cardiometabolic Disease

Sites in Miami, Jacksonville +8 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06585462·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for Hematologic Malignancies

Sites in Tampa +9 more locations

Sponsor: Sellas Life Sciences Group

Sex: All·Age: 12+

Code: NCT04588922·Phase 1, Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for B-cell Malignancy

Sites in Tampa, Jacksonville +16 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06634589·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for Lung Cancer

Sites in Miami +11 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06618287·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

for Relapsed/Refractory Acute Myeloid Leukemia

Sites in Tampa +17 more locations

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT06714591·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for Relapsed/Refractory Multiple Myeloma

Drug: Daratumumab

Sites in Miami +14 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT04973605·Phase 1, Phase 2·Recruiting·Listed Jul 2021

Apply to this trial

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Celebration +10 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06589596·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

for Ulcerative Colitis

Sites in Miami, Kissimmee +12 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18 - 80

Code: NCT06636656·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

for Mesial Temporal Lobe Epilepsy

Sites in Jacksonville +17 more locations

Sponsor: UniQure Biopharma B.V.

Sex: All·Age: 18 - 75

Code: NCT06063850·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

for Pulmonary Embolism

Sites in Naples, Bradenton +11 more locations

Sponsor: Innova Vascular, Inc.

Sex: All·Age: 18 - 85

Code: NCT06041594·Recruiting·Listed Sep 2023

Apply to this trial

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

for Ovarian Cancer

Sites in Jacksonville +9 more locations

Sponsor: NX Development Corp

Sex: Female·Age: 18+

Code: NCT05804370·Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

for Episodic Migraine

Sites in Tampa, Hialeah +8 more locations

Sponsor: H. Lundbeck A/S

Sex: All·Age: 6 - 17

Code: NCT05897320·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for IC-MPGN

Drug: Iptacopan

Sites in Miami +21 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 60

Code: NCT05755386·Phase 3·Recruiting·Listed Mar 2023

Apply to this trial

Investigations of Reproductive Cancers in Women

for Uterine Cancer

Sites in Orlando +12 more locations

Sponsor: PinkDx, Inc.

Sex: Female·Age: 45 - 100

Code: NCT06527157·Recruiting·Listed Jul 2024

Apply to this trial

STOP AF First Post-Approval Study

for Paroxysmal Atrial Fibrillation

Sites in Clearwater, Davie +8 more locations

Sponsor: Medtronic Cardiac Ablation Solutions

Sex: All·Age: 18+

Code: NCT05227053·Recruiting·Listed Feb 2022

Apply to this trial

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

for Thyroid Eye Disease

Sites in Jacksonville, Sarasota +10 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06401044·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for SLE

Sites in Orlando +9 more locations

Sponsor: Cullinan Therapeutics Inc.

Sex: All·Age: 18 - 70

Code: NCT06613360·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

for Muscular Atrophy, Spinal

Sites in Gainesville +8 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 3 Months - 24 Months

Code: NCT05861999·Phase 4·Recruiting·Listed May 2023

Apply to this trial

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

for Advanced Solid Tumor

Drug: NXP900

Sites in Jacksonville +12 more locations

Sponsor: Nuvectis Pharma, Inc.

Sex: All·Age: 18+

Code: NCT05873686·Phase 1·Recruiting·Listed May 2023

Apply to this trial